Literature DB >> 21531882

Thrombocytopenia in Staphylococcus aureus bacteremia: risk factors and prognostic importance.

Anat Gafter-Gvili1, Nariman Mansur, Assaf Bivas, Noa Zemer-Wassercug, Jihad Bishara, Leonard Leibovici, Mical Paul.   

Abstract

OBJECTIVE: To identify risk factors and outcomes associated with thrombocytopenia at sepsis onset in Staphylococcus aureus bacteremia. PATIENTS AND METHODS: This single-center, retrospective, cohort study consists of all adult patients with a first episode of clinical S aureus bacteremia between April 1, 1988, and September 30, 1994, and between January 1, 1999, and December 31, 2007. Thrombocytopenia was defined as a platelet count less than 150 × 10(9)/L. The primary outcome was 30-day all-cause mortality. Risk factors for 30-day all-cause mortality were identified using univariate and multivariable analyses. Multivariable analysis was conducted using forward step logistic regression analysis. Odds ratios (ORs) with 95% confidence intervals (CIs) were calculated for risk of death.
RESULTS: A total of 1052 patients had clinical S aureus bacteremia. Thrombocytopenia at sepsis onset was present in 235 patients (22.3%). Thrombocytopenia was associated with community-acquired bacteremia, infections caused by methicillin-sensitive S aureus, high-magnitude bacteremia (defined as >4 positive blood cultures [≥ 3 separate positive blood culture sets]), and endocarditis. Patients with thrombocytopenia presented more commonly with severe sepsis reflected by septic shock and acute renal failure. Thirty-day mortality was significantly higher among patients with thrombocytopenia (132/235 [56.2%]) vs those without thrombocytopenia (281/817 [34.4%]; P<.001). Higher mortality was associated with the degree of thrombocytopenia. In multivariable analysis, thrombocytopenia at baseline remained an independent risk factor for 30-day mortality (OR, 2.82; 95% CI, 1.87-4.24). The adjusted association between thrombocytopenia and death remained similar among the 917 patients with monomicrobial bacteremia (OR, 2.88; 95% CI, 1.83-4.53) and the 945 patients who did not die within the first 48 hours (OR, 2.88; 95% CI, 1.87-4.45.).
CONCLUSION: We observed a strong association between thrombocytopenia at sepsis onset and all-cause mortality in S aureus bacteremia, possibly related to mechanisms other than sepsis alone.

Entities:  

Mesh:

Year:  2011        PMID: 21531882      PMCID: PMC3084641          DOI: 10.4065/mcp.2010.0705

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN: 0025-6196            Impact factor:   7.616


  37 in total

1.  Thrombocytopenia in the sepsis syndrome: role of hemophagocytosis and macrophage colony-stimulating factor.

Authors:  B François; F Trimoreau; P Vignon; P Fixe; V Praloran; H Gastinne
Journal:  Am J Med       Date:  1997-08       Impact factor: 4.965

Review 2.  Platelets in sepsis.

Authors:  Marcel Levi
Journal:  Hematology       Date:  2005       Impact factor: 2.269

3.  Acetylsalicylic acid reduces vegetation bacterial density, hematogenous bacterial dissemination, and frequency of embolic events in experimental Staphylococcus aureus endocarditis through antiplatelet and antibacterial effects.

Authors:  L I Kupferwasser; M R Yeaman; S M Shapiro; C C Nast; P M Sullam; S G Filler; A S Bayer
Journal:  Circulation       Date:  1999-06-01       Impact factor: 29.690

4.  Role of hemophagocytic histiocytosis in the etiology of thrombocytopenia in patients with sepsis syndrome or septic shock.

Authors:  F Stéphan; B Thiolière; E Verdy; M Tulliez
Journal:  Clin Infect Dis       Date:  1997-11       Impact factor: 9.079

5.  Mortality risk factors with nosocomial Staphylococcus aureus infections in intensive care units: results from the German Nosocomial Infection Surveillance System (KISS).

Authors:  P Gastmeier; D Sohr; C Geffers; M Behnke; F Daschner; H Rüden
Journal:  Infection       Date:  2005-04       Impact factor: 3.553

6.  Community-acquired Staphylococcus aureus bacteraemia in patients who do not abuse intravenous drugs.

Authors:  P A Willcox; B L Rayner; D A Whitelaw
Journal:  QJM       Date:  1998-01

Review 7.  Septic shock.

Authors:  Djillali Annane; Eric Bellissant; Jean-Marc Cavaillon
Journal:  Lancet       Date:  2005 Jan 1-7       Impact factor: 79.321

8.  Diminished platelet binding in vitro by Staphylococcus aureus is associated with reduced virulence in a rabbit model of infective endocarditis.

Authors:  P M Sullam; A S Bayer; W M Foss; A L Cheung
Journal:  Infect Immun       Date:  1996-12       Impact factor: 3.441

9.  Staphylococcus aureus induces platelet aggregation via a fibrinogen-dependent mechanism which is independent of principal platelet glycoprotein IIb/IIIa fibrinogen-binding domains.

Authors:  A S Bayer; P M Sullam; M Ramos; C Li; A L Cheung; M R Yeaman
Journal:  Infect Immun       Date:  1995-09       Impact factor: 3.441

Review 10.  Multiple organ dysfunction score: a reliable descriptor of a complex clinical outcome.

Authors:  J C Marshall; D J Cook; N V Christou; G R Bernard; C L Sprung; W J Sibbald
Journal:  Crit Care Med       Date:  1995-10       Impact factor: 7.598

View more
  22 in total

1.  Protein kinase A determines platelet life span and survival by regulating apoptosis.

Authors:  Lili Zhao; Jun Liu; Chunyan He; Rong Yan; Kangxi Zhou; Qingya Cui; Xingjun Meng; Xiaodong Li; Yang Zhang; Yumei Nie; Yang Zhang; Renping Hu; Yancai Liu; Lian Zhao; Mengxing Chen; Weiling Xiao; Jingluan Tian; Yunxiao Zhao; Lijuan Cao; Ling Zhou; Anning Lin; Changgeng Ruan; Kesheng Dai
Journal:  J Clin Invest       Date:  2017-10-30       Impact factor: 14.808

2.  Thrombocytopaenia during methicillin-sensitive Staphylococcus aureus bacteraemia.

Authors:  E Forsblom; I Tielinen; E Ruotsalainen; A Järvinen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-12-23       Impact factor: 3.267

3.  Impact of Clopidogrel on Clinical Outcomes in Patients with Staphylococcus aureus Bacteremia: a National Retrospective Cohort Study.

Authors:  Aisling R Caffrey; Haley J Appaneal; Kerry L LaPlante; Vrishali V Lopes; Erlinda R Ulloa; Victor Nizet; George Sakoulas
Journal:  Antimicrob Agents Chemother       Date:  2022-04-13       Impact factor: 5.938

4.  Bacteria differentially induce degradation of Bcl-xL, a survival protein, by human platelets.

Authors:  Bjoern F Kraemer; Robert A Campbell; Hansjörg Schwertz; Zechariah G Franks; Adriana Vieira de Abreu; Katharina Grundler; Benjamin T Kile; Bijaya K Dhakal; Matthew T Rondina; Walter H A Kahr; Matthew A Mulvey; Robert C Blaylock; Guy A Zimmerman; Andrew S Weyrich
Journal:  Blood       Date:  2012-10-18       Impact factor: 22.113

5.  Multivalvular infective endocarditis in pregnancy presenting with septic pulmonary emboli.

Authors:  Nicola English; Polly Weston
Journal:  BMJ Case Rep       Date:  2015-05-07

6.  Platelet and neutrophil responses to Gram positive pathogens in patients with bacteremic infection.

Authors:  Daniel Johansson; Oonagh Shannon; Magnus Rasmussen
Journal:  PLoS One       Date:  2011-11-29       Impact factor: 3.240

7.  Repurposed drugs block toxin-driven platelet clearance by the hepatic Ashwell-Morell receptor to clear Staphylococcus aureus bacteremia.

Authors:  Josh Sun; Satoshi Uchiyama; Joshua Olson; Yosuke Morodomi; Ingrid Cornax; Nao Ando; Yohei Kohno; May M T Kyaw; Bernice Aguilar; Nina M Haste; Sachiko Kanaji; Taisuke Kanaji; Warren E Rose; George Sakoulas; Jamey D Marth; Victor Nizet
Journal:  Sci Transl Med       Date:  2021-03-24       Impact factor: 19.319

8.  Etiology of thrombocytosis in a general medicine population: analysis of 801 cases with emphasis on infectious causes.

Authors:  Stacey R Rose; Nancy J Petersen; Tracie J Gardner; Richard J Hamill; Barbara W Trautner
Journal:  J Clin Med Res       Date:  2012-11-11

9.  Thrombocytopenia in bacteraemia and association with bacterial species.

Authors:  D Johansson; M Rasmussen; M Inghammar
Journal:  Epidemiol Infect       Date:  2018-05-15       Impact factor: 4.434

10.  Platelet mitochondrial membrane depolarization reflects disease severity in patients with sepsis and correlates with clinical outcome.

Authors:  Katharina Gründler; Matthias Angstwurm; Robert Hilge; Philipp Baumann; Thorsten Annecke; Alexander Crispin; Hae-Young Sohn; Steffen Massberg; Bjoern F Kraemer
Journal:  Crit Care       Date:  2014-02-12       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.